OraPharma, Inc. Selects Learn HealthSci for Arestin Online Training
Monday, April 12, 2010
Orapharma, a subsidiary of Johnson & Johnson, has contracted with Learn HealthSci for the production and online distribution of two new training modules on Arestin. The modules will be designed to train Henry Schein sales reps and U.S. dentists on the new Arestin Rx Access program.
Founded in 1996, OraPharma, Inc. is a specialty healthcare company that discovers, develops, and commercializes products that maintain and restore oral health. In 2002, OraPharma, Inc. was acquired by the Johnson & Johnson Family of Companies.OraPharma, Inc.'s lead product, ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg, is indicated as an adjunct to scaling and root planing (SRP) procedures for the reduction of pocket depth in patients with adult periodontitis. In addition, OraPharma, Inc. distributes OSSIX™ PLUS™ (resorbable collagen membrane), a product used in guided bone regeneration (GBR) and guided tissue regeneration (GTR) procedures.
Learn HealthSci Inc. is a privately held company based in San Diego, CA, specializing in web-based multimedia training and software development in the health care sector. Learn HealthSci provides cost-effective e-learning solutions to medium and large size companies, many of which are among the Fortune 500. For more information visit: www.learnhealthsci.com